Senile acute myeloid leukemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who meet the diagnostic criteria for AML; (2)Patients over the age of 60 (3) The patient was generally in good condition, with a KPS score of 60; (4) Patients admitted to the hospital for chemotherapy; (5) The expected survival period is greater than 3 months; (6) The patient participated voluntarily and signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with central nervous system leukemia; (2) Patients with platelet count less than 10109 / L; (3) Skin damage and other reasons are not suitable for moxibustion; (4) With severe organ function injury and other complications, it cannot tolerate chemotherapy; (5) Mental abnormalities and other circumstances can not cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peripheral white blood cell count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Peripheral blood neutrophils\platelet\hemoglobin;Coagulation function\c-reactive protein;Interval and rate of rechemotherapy;Major symptom score;Amount of blood transfused during treatment (including red cell suspension and platelet collection);Percentage of bone marrow original cells;Incidence of infection and bleeding (urinary, digestive, oral, nasal) in patients during chemotherapy;KarnofskyPerformance Status;Bone marrow original cell count; | — |
Countries
China
Contacts
Xi Yuan Hospital of China Academy of Chinese Medical Sciences